Robuta

Sponsor of the Day: Jerkmate
https://www.jci.org/articles/view/199048 JCI - MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy jcimekinhibitormirdametinibpromotes https://springworkstx.com/pipeline/mirdametinib/ Mirdametinib - NF1 Treatment - SpringWorks Therapeutics Feb 28, 2025 - Mirdametinib is an oral small molecule designed to inhibit MEK1 and MEK2, which are proteins that occupy pivotal positions in the MAPK pathway. springworks therapeuticsmirdametinibnf1treatment https://www.jci.org/articles/view/199048/pdf JCI - MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy jcimekinhibitormirdametinibpromotes